A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Study of ONO-8539 in Patients With Overactive Bladder

NCT00876421 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

NCT00966004 ·Status: COMPLETED ·Phase: PHASE3

Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

NCT00746681 ·Status: COMPLETED ·Phase: PHASE2

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

NCT00798434 ·Status: COMPLETED ·Phase: PHASE4

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

NCT00561951 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects

NCT02821312 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

NCT00137397 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics and Relative Bioavailability Study

NCT01521767 ·Status: COMPLETED ·Phase: PHASE1

ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)

NCT00439192 ·Status: TERMINATED ·Phase: PHASE2

Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients

NCT00730535 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

NCT01302054 ·Status: COMPLETED ·Phase: PHASE4

Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

NCT03175029 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

NCT00335660 ·Status: TERMINATED ·Phase: PHASE2

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

NCT00444925 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

NCT00645281 ·Status: COMPLETED ·Phase: PHASE4

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)

NCT01488578 ·Status: COMPLETED

Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder

NCT01302938 ·Status: TERMINATED ·Phase: PHASE4

Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

NCT00658684 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder

NCT00836381 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB

NCT02485067 ·Status: COMPLETED ·Phase: PHASE3

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

NCT04305743 ·Status: RECRUITING ·Phase: PHASE4

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01604928 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

NCT00611026 ·Status: COMPLETED ·Phase: PHASE3